Register entry

Ardelyx, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
4
Live patents
24
Exclusivities
1
Countries
0
Catalogue

Drug listings by form and route

4

4 active NDC listings: 4 human prescription drug. By marketing category: NDA 4.

Dosage formNDCs
tablet, film coated3
tablet1
RouteNDCs
oral4
Labeller name on the listingNDCs
ardelyx, inc.4
Exclusivity

Patents and exclusivities

24
PatentProductCoversExpiry
12016856IBSRELA, XPHOZAHtenapanor hydrochloridesubstance, productDec 2029
8969377IBSRELA, XPHOZAHtenapanor hydrochloridesubstance, productDec 2029
9408840IBSRELAtenapanor hydrochlorideuseDec 2029
9006281IBSRELAtenapanor hydrochlorideuseMay 2030
8541448IBSRELA, XPHOZAHtenapanor hydrochloridesubstance, productAug 2033
10272079XPHOZAHtenapanor hydrochlorideuseApr 2034
10940146XPHOZAHtenapanor hydrochlorideuseApr 2034
12539299IBSRELA, XPHOZAHtenapanor hydrochlorideproductNov 2042
ProductExclusivityUntil
XPHOZAHTENAPANOR HYDROCHLORIDENP New productOct 2026
Catalogue

Marketed products

4
BrandGeneric nameForm / routeNDC
IBSRELAtenapanor hydrochloridetablet, oral73154-050NDA
XPHOZAH 10 mgTenapanortablet, film coated, oral73154-110NDA
XPHOZAH 20 mgTenapanortablet, film coated, oral73154-120NDA
XPHOZAH 30 mgTenapanortablet, film coated, oral73154-130NDA
Compare

Other companies listing tenapanor

Enquiry

Common questions

Is Ardelyx, Inc. FDA approved?
Ardelyx, Inc. holds no registered establishment of its own; 4 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Ardelyx, Inc. make?
4 products are listed under Ardelyx, Inc. in the openFDA NDC Directory, most often as tablet, film coated; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.